Ligand validation:6ZOC

PTY: PHOSPHATIDYLETHANOLAMINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZOC_PTY_C_1113	6%	49%	0.369	0.815	0.94	1.03	2	3	3	0	100%	1
6ZOD_PTY_C_1303	11%	49%	0.347	0.863	0.93	1.04	2	4	2	0	100%	1
5JMN_PTY_C_1111	9%	51%	0.259	0.754	0.99	0.92	2	3	0	0	100%	1
6ZO8_PTY_C_1104	9%	89%	0.276	0.765	0.26	0.37	-	-	0	0	100%	1
6Q4O_PTY_C_1116	6%	90%	0.301	0.738	0.28	0.32	-	-	1	0	100%	1
6ZO9_PTY_C_1109	6%	90%	0.317	0.751	0.26	0.36	-	-	0	0	100%	1
6SNY_PTY_B_200	72%	73%	0.138	0.963	0.47	0.58	-	1	5	0	100%	1
1LQV_PTY_B_607	61%	63%	0.119	0.906	0.85	0.58	3	-	0	0	100%	1
3JTC_PTY_B_607	39%	37%	0.169	0.877	1.1	1.36	4	5	2	0	100%	1
4N31_PTY_B_201	39%	44%	0.173	0.917	0.71	1.42	-	3	1	0	78%	0.75
3W5A_PTY_B_1003	38%	22%	0.101	0.915	1.58	1.68	2	2	1	0	38%	0.38

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.